Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/1999
11/18/1999WO1999050393A3 Use of stimulated peripheral blood mononuclear cells for the treatment of brain-related diseases, disorders and damage
11/18/1999WO1999049856A3 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
11/18/1999WO1999049854A3 Use of dexmedetomidine for icu sedation
11/18/1999WO1999046283A9 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
11/18/1999WO1999046281A9 Novel polypeptides and nucleic acids encoding the same
11/18/1999WO1999045949A3 Use of follistatin to modulate gdf-8 and bmp-11
11/18/1999WO1999037682A3 Antibodies against human il-12
11/18/1999WO1999027098A3 A-33 related antigens and their pharmacological uses
11/18/1999DE19822036A1 Effervescent pharmaceutical composition with improved stability
11/18/1999DE19821483A1 New imidazolidine derivatives useful as leukocyte adhesion and migration inhibitors and/or VLA-4 receptor antagonists for treating E.G. inflammatory and allergic disorders
11/18/1999DE19821003A1 New dihydro-indazolone derivatives useful as antiasthmatic, antiallergic and neuroprotective agents and for treatment of inflammation and immune disorders
11/18/1999CA2332275A1 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
11/18/1999CA2332021A1 Diagnosis of predisposition to epilepsy and monitoring of antiepileptic treatment
11/18/1999CA2331871A1 Novel formulation containing paroxetine
11/18/1999CA2331866A1 Process for preparation of 4,5-epoxymorphinan-6-oxyglucuronides
11/18/1999CA2331849A1 Novel formulation containing paroxetine
11/18/1999CA2331735A1 Phenylurea and phenylthio urea derivatives
11/18/1999CA2331542A1 Antidepressant therapy
11/18/1999CA2331371A1 Water-soluble pro-drugs of propofol
11/18/1999CA2330796A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2330095A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2328062A1 Secreted proteins and polynucleotides encoding them
11/18/1999CA2327523A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use
11/18/1999CA2327345A1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors
11/18/1999CA2326105A1 New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol
11/17/1999EP0957102A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
11/17/1999EP0957099A2 Heterocyclic carboxamides
11/17/1999EP0956358A2 Cd95 regulatory gene sequences and transcription factors
11/17/1999EP0956292A1 Conantokins
11/17/1999EP0956289A1 Novel prokaryotic polynucleotides, polypeptides and their uses
11/17/1999EP0956287A1 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function
11/17/1999EP0956281A1 Novel modifications to 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonyl-aminobenzene and processes for preparing said compound
11/17/1999EP0956043A1 Strain selection of pneumococcal surface proteins
11/17/1999EP0956040A1 Stimulation of host defense mechanisms against viral challenges
11/17/1999EP0956026A1 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
11/17/1999EP0956020A1 Use of 2-(4-methoxyphenyl)-pyrazolo(4,3-c)quinolin-3-one in the manufacture of a medicament for enhancing cognition
11/17/1999EP0956013A1 Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
11/17/1999EP0956011A1 Use of arachidonic acid and/or docosahexanoic acid for the manufacture of a medicament for the treatment of dyspraxia
11/17/1999EP0956010A1 Pharmaceutical microspheres of valproic acid for oral administration
11/17/1999EP0956009A1 Treatment of neurodegenerative conditions with nimesulide
11/17/1999EP0955808A1 Human g-protein coupled receptor
11/17/1999EP0880352B1 Stabilization of naloxone hydrochloride
11/17/1999EP0707477B1 Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
11/17/1999CN1235606A 2-methoxyphenylpiperazine derivatives
11/17/1999CN1235604A Benzoxazole derivative with affinity to binding sites of amino acid receptors
11/17/1999CN1235603A N-substituted azaheterocyclic compounds
11/17/1999CN1235544A Controlled release dosage form of R-(Z)-alpha-methoxyimino-alpha-(1-azabicyclo 2,2 oct-c-yl) acetonitrile monohydrochloride
11/17/1999CN1235541A Treatment of spasticity, convulsions by isovaleric acid derivatives CNS
11/17/1999CN1235540A Use of adamantane amines or structurally similar compounds for combating borna disease virus and for prevention and treatment of affective diseases and other disorders associated with BDV infections i
11/17/1999CN1235040A Agent for stopping smoking
11/17/1999CN1046519C Oxazolyl- and thiazolylimidazo- and thienodiazepines and use as medicaments
11/17/1999CN1046518C Heterocyclic subtituted imidazoloquinoxalinones, preparation and use thereof
11/17/1999CN1046515C Diazabicyclic neurokinin antagonists
11/17/1999CN1046514C Melatonin agonist 'beta-carboline derivatives and analogs with naphthalenic structure, preparation thereof and their use as drugs
11/17/1999CN1046512C Mercaptoacetylamide disulfide derivatives, preparation thereof and medicinal composition containing the same
11/17/1999CN1046511C Benzoylecgonine, ecgonine and ecgonidine derivatives
11/17/1999CN1046507C Heterocyclic compounds for treatment of CNS and cardiovasular disorders
11/17/1999CN1046506C Preparation of n-tert-butylamides derivatives and their salts
11/17/1999CN1046505C Preparation of 1-benzyl-3-hydroxymethyl-indazole and ether of aliphatic-2-hydroxy acid
11/16/1999US5986114 Benzopyranol derivatives
11/16/1999US5986100 Pharmaceutical compositions and methods for use
11/16/1999US5986069 Human haemopoietic maturation factor polypeptides
11/16/1999US5986058 Growth differentiation factor with amino acid sequences
11/16/1999US5986054 Genetic sequences and proteins related to alzheimer's disease
11/16/1999US5985930 Treatment of neurodegenerative conditions with nimesulide
11/16/1999US5985917 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
11/16/1999US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999US5985896 Piperidine and morpholine derivatives and their use as therapeutic agents
11/16/1999US5985895 2-naphthamide derivatives and their therapeutic applications
11/16/1999US5985894 Useful in the treatment of cardiovascular illnesses
11/16/1999US5985887 Aza-anthracyclinone derivatives
11/16/1999US5985871 Benzoxazine compounds for enhancing synaptic response
11/16/1999US5985866 Use of serotonin antagonists for treating fibromyalgia
11/16/1999US5985600 Nucleic acid encoding delta opioid receptor
11/16/1999US5985334 Contacting test compound to receptor from rat brain tissue that binds 6-acetyl-4-benzamido-3-hydroxy-2,2-dimethylbenzopyran derivatives
11/16/1999US5985322 Enteric administering of pellet with fluoxetine core and hydroxypropylmethyl cellulose acetate succinate layer; side effect reduction
11/16/1999US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation.
11/16/1999CA2137811C Dimeric piperidine, tetrahydropyridine and piperazine derivatives
11/16/1999CA2064815C Therapeutic heterocyclic compounds
11/16/1999CA2013599C Aryl-substituted rhodanine derivatives
11/16/1999CA1340824C Neurokinin a antagonists
11/13/1999CA2248987A1 Novel compounds
11/11/1999WO1999057303A1 A method for diagnosing and treating chronic pelvic pain syndrome
11/11/1999WO1999057290A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/11/1999WO1999057288A1 Endothelin-converting-enzyme like protein
11/11/1999WO1999057270A2 Human receptor molecules
11/11/1999WO1999057241A2 Myelin basic protein peptides and uses thereof
11/11/1999WO1999057149A2 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/11/1999WO1999057115A1 Novel benzimidazoles and benzoxazoles
11/11/1999WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
11/11/1999WO1999057101A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999WO1999056770A2 Novel therapy for treatment of lysosomal storage disease
11/11/1999WO1999056765A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
11/11/1999WO1999056763A1 Use of neglected target tissue antigens in modulation of immune responses
11/11/1999WO1999056751A1 Aqueous process for manufacturing paroxetine solid dispersions
11/11/1999WO1999056750A1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
11/11/1999WO1999056745A1 New use
11/11/1999WO1999056737A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999WO1999047132A3 Heterocyclic compounds, their production and use as tachykinin receptor antagonists
1 ... 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 ... 1833